• Risk factors and outcomes associated with recurrent autoimmune hepatitis 

  Montano-Loza, AJ; Ronca, V; Ebadi, M; Hansen, BE; Hirschfield, G; Elwir, S; Alsaed, M; Milkiewicz, P; Janik, MK; Marschall, HU; Burza, MA; Efe, C; Caliskan, AR; Harputluoglu, M; Kabacam, G; Terrabuio, D; Onofrio, FD; Selzner, N; Bonder, A; Pares, A; Llovet, L; Akyildiz, M; Arikan, C; Manns, MP; Taubert, R; Weber, AL; Schiano, TD; Haydel, B; Czubkowski, P; Socha, P; Oldak, N; Akamatsu, N; Tanaka, A; Levy, C; Martin, EF; Goel, A; Sedki, M; Jankowska, I; Ikegami, T; Rodriguez, M; Sterneck, M; Weiler-Normann, C; Schramm, C; Donato, MF; Lohse, A; Andrade, RJ; Patwardhan, VR; van Hoek, B; Biewenga, M; Kremer, AE; Ueda, Y; Deneau, M; Pedersen, M; Mayo, MJ; Floreani, A; Burra, P; Secchi, MF; Beretta-Piccoli, BT; Sciveres, M; Maggiore, G; Jafri, SM; Debray, D; Girard, M; Lacaille, F; Lytvyak, E; Mason, AL; Heneghan, M; Oo, YH (2022)

  Background & Aims: Autoimmune hepatitis can recur after liver transplantation (LT), though the impact of recurrence on patient and graft survival has not been well characterized. We evaluated a large, international, ...
• Management of granulomatous lobular mastitis: an international 

  Yuan, QQ; Xiao, SY; Farouk, O; Du, YT; Sheybani, F; Tan, QT; Akbulut, S; Cetin, K; Alikhassi, A; Yaghan, RJ; Durur-Subasi, I; Altintoprak, F; Eom, TI; Alper, F; Hasbahceci, M; Martinez-Ramos, D; Oztekin, PS; Kwong, A; Pluguez-Turull, CW; Brownson, KE; Chandanwale, S; Habibi, M; Lan, LY; Zhou, R; Zeng, XT; Bai, J; Bai, JW; Chen, QR; Chen, X; Zha, XM; Dai, WJ; Dai, ZJ; Feng, QY; Gao, QJ; Gao, RF; Han, BS; Hou, JX; Hou, W; Liao, HY; Luo, H; Liu, ZR; Lu, JH; Luo, B; Ma, XP; Qian, J; Qin, JY; Wei, W; Wei, G; Xu, LY; Xue, HC; Yang, HW; Yang, WG; Zhang, CJ; Zhang, F; Zhang, GX; Zhang, SK; Zhang, SQ; Zhang, YQ; Zhang, YP; Zhang, SC; Zhao, DW; Zheng, XM; Zheng, LW; Xu, GR; Zhou, WB; Wu, GS (2022)
• THE LONGITUDINAL EVOLUTION OF COVID-19 OUTCOMES AMONG HEMODIALYSIS 

  Ozturk, S; Turgutalp, K; Arici, M; Gorgulu, N; Tonbul, HZ; Eren, N; Gencer, V; Ayli, D; Pembegul, I; Dolarslan, ME; Ural, Z; Colak, H; Ozler, TE; Can, O; Demir, ME; Altunoren, O; Huddam, B; Onec, K; Demirelli, B; Aydin, Z; Altun, E; Alagoz, S; Ayar, Y; Eser, ZE; Comma, BB; Yilmaz, Z; Ates, EU; Yuksel, E; Sahin, GK; Aktar, M; Cebeci, E; Dursun, B; Kocak, SY; Yildiz, A; Kazan, S; Gok, M; Erkan, S; Tugcu, M; Ozturk, R; Kahvecioglu, S; Kara, E; Kaya, B; Sahin, G; Sakaci, T; Sipahi, S; Kurultak, I; Durak, BA; Altiparmak, MR; Ecder, SA; Karadag, S; Dincer, MT; Ozer, H; Bek, S; Ulu, S; Gungor, O; Bakir, EA; Odabas, AR; Seyahi, N; Ates, K (2022)
• Management of granulomatous lobular mastitis: an international 

  Yuan, QQ; Xiao, SX; Farouk, O; Du, YT; Sheybani, F; Tan, QT; Akbulut, S; Cetin, K; Alikhassi, A; Yaghan, RJ; Durur-Subasi, I; Altintoprak, F; Eom, TI; Alper, F; Hasbahceci, M; Martinez-Ramos, D; Oztekin, PS; Kwong, A; Pluguez-Turull, CW; Brownson, KE; Chandanwale, S; Habibi, M; Lan, LY; Zhou, R; Zeng, XT; Bai, J; Bai, JW; Chen, QR; Chen, X; Zha, XM; Dai, WJ; Dai, ZJ; Feng, QY; Gao, QJ; Gao, RF; Han, BS; Hou, JX; Hou, W; Liao, HY; Luo, H; Liu, ZR; Lu, JH; Luo, B; Ma, XP; Qian, J; Qin, JY; Wei, W; Wei, G; Xu, LY; Xue, HC; Yang, HW; Yang, WG; Zhang, CJ; Zhang, F; Zhang, GX; Zhang, SK; Zhang, SQ; Zhang, YQ; Zhang, YP; Zhang, SC; Zhao, DW; Zheng, XM; Zheng, LW; Xu, GR; Zhou, WB; Wu, GS (2022)

  Granulomatous lobular mastitis (GLM) is a rare and chronic benign inflammatory disease of the breast. Difficulties exist in the management of GLM for many front-line surgeons and medical specialists who care for patients ...
• The Longitudinal Evolution of Post-COVID-19 Outcomes Among Hemodialysis 

  Ozturk, S; Turgutalp, K; Arici, M; Gorgulu, N; Tonbul, HZ; Eren, N; Gencer, V; Ayli, MD; Pembegul, I; Dolarslan, ME; Ural, Z; Colak, H; Ozler, TE; Can, O; Demir, ME; Altunoren, O; Huddam, B; Onec, K; Demirelli, B; Aydin, Z; Altun, E; Alagoz, S; Ayar, Y; Eser, ZE; Berktas, B; Yilmaz, Z; Ates, EU; Yuksel, E; Sahin, GK; Aktar, M; Cebeci, E; Dursun, B; Kocak, SY; Yildiz, A; Kazan, S; Gok, M; Sengul, E; Tugcu, M; Ozturk, R; Kahvecioglu, S; Kara, E; Kaya, B; Sahin, G; Sakaci, T; Sipahi, S; Kurultak, I; Durak, BA; Altiparmak, MR; Ecder, SA; Karadag, S; Dincer, MT; Ozer, H; Bek, SG; Ulu, MS; Gungor, O; Bakir, EA; Odabas, AR; Seyahi, N; Ates, K (2022)

  Introduction: Hemodialysis (HD) patients have increased risk for short-term adverse outcomes of COVID-19. However, complications and survival at the post-COVID-19 period have not been published extensively.Methods: We ...
• Pregnancy and its outcomes in hemodialysis patients in Turkey 

  Dheir, H; Gungor, O; Ulu, MS; Oguz, EG; Eren, N; Altunoren, O; Tatar, E; Atilgan, KG; Karakose, S; Guney, I; Eroglu, E; Mutluay, R; Bozaci, I; Alp, A; Akdam, H; Demirci, MS; Soypacaci, Z; Akarsu, O; Payda, S; Ercan, Z; Kara, E; Topal, C; Yava, HH; Tekkarismaz, N; Turgutalp, K; Huzmeli, C; Inci, A; Karaveli Gursoy, G; Gunes Keskin, AJ; Huddam, B; Hur, E; Yildiz, A; Bekfilavioglu, G; Sahutoglu, T; Tuncay, M; Bardak, S; Bakirdogen, S; Yilmaz, Z; Gunay, E; Tunca, O; Kazan, S; Yigit, IP; Sarita, H; Sevinc, C; Kaptanogullari, H; Gokcay Bek, S; Kurultak, I; Degirmenci, A; Sakaci, M; Kilic, I; Aydin, Z; Colak, H; Dervisoglu, E; Sahin, G; Ayli, MD; Sipahi, S; Derici, U (2022)

  Background/aim: This study aimed to investigate pregnancy frequency and evaluate the factors affecting live births in hemodialysis (HD) patients. Materials and methods: Female HD patients whose pregnancy was retrospectively ...
• Liver injury after SARS-CoV-2 vaccination: Features of immune-mediated 

  Efe, C; Kulkarni, AV; Beretta-Piccoli, BT; Magro, B; Stattermayer, AF; Cengiz, M; Clayton-Chubb, D; Lammert, C; Bernsmeier, C; Gul, O; Higuera-de la Tijera, FH; Anders, M; Lytvyak, E; Akin, M; Purnak, T; Liberal, R; Peralta, M; Ebik, B; Duman, S; Demir, N; Balaban, Y; Urzua, A; Contreras, F; Venturelli, MG; Bilgic, Y; Medina, A; Girala, M; Gunsar, F; Londono, MC; Androutsakos, T; Kisch, A; Yurci, A; Guzelbult, F; Cagin, YF; Avci, E; Guzelbulut, M; Dindar-Demiray, EK; Harputluoglu, M; Kumar, R; Satapathy, SK; Mendizabal, M; Silva, M; Fagiuoli, S; Roberts, SK; Soylu, NK; Idilman, R; Yoshida, EM; Montano-Loza, AJ; Dalekos, GN; Ridruejo, E; Schiano, TD; Wahlin, S (2022)

  Background and Aims A few case reports of autoimmune hepatitis-like liver injury have been reported after severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccination. We evaluated clinical features, treatment ...
• Physical properties of the trans-Neptunian object (38628) Huya from a 

  Santos-Sanz, P; Ortiz, JL; Sicardy, B; Popescu, M; Benedetti-Rossi, G; Morales, N; Vara-Lubiano, M; Camargo, JIB; Pereira, CL; Rommel, FL; Assafin, M; Desmars, J; Braga-Ribas, F; Duffard, R; Oliveira, JM; Vieira-Martins, R; Fernandez-Valenzuela, E; Morgado, BE; Acar, M; Anghel, S; Atalay, E; Ates, A; Bakis, H; Bakis, V; Eker, Z; Erece, O; Kaspi, S; Kayhan, C; Kilic, SE; Kilic, Y; Manulis, I; Nedelcu, DA; Niaei, MS; Nir, G; Ofek, E; Ozisik, T; Petrescu, E; Satir, O; Solmaz, A; Sonka, A; Tekes, M; Unsalan, O; Yesilyaprak, C; Anghel, R; Curelaru, L; Danescu, C; Dumitrescu, V; Gherase, R; Hudin, L; Stoian, AM; Tercu, JO; Truta, R; Turcu, V; Vantdevara, C; Belskaya, I; Dementiev, TO; Gazeas, K; Karampotsiou, S; Kashuba, V; Kiss, C; Koshkin, N; Kozhukhov, OM; Krugly, Y; Lecacheux, J; Pal, A; Szakats, R; Zhukov, V; Bamberger, D; Mondon, B; Pratt, A; Schnabel, C; Selva, A; Teng, JP; Tigani, K; Tsamis, V; Weber, C; Wells, G; Kalkan, S; Kudak, V; Marciniak, A; Ogloza, W; Ozdemir, T; Pakstiene, E; Perig, V; Zejmo, M; Puskullu, C (2022)

  Context. As part of our international program aimed at obtaining accurate physical properties of trans-Neptunian objects (TNOs), we predicted a stellar occultation by the TNO (38628) Huya of the star Gaia DR2 4352760586390566400 ...
• Epidemiologic and clinical characteristics of neonates with late-onset 

  Akin, IM; Kanburoglu, MK; Tayman, C; Oncel, MY; Imdadoglu, T; Dilek, M; Yaman, A; Narter, F; Er, I; Kahveci, H; Erdeve, O; Koc, E (2022)

  The literature on neonates with SARS-CoV-2 is mainly concerned with perinatal cases, and scanty data are available about environmentally infected neonates. To fill knowledge gaps on the course and prognosis of neonatal ...
• Prevalence of Vitamin D Deficiency and Hypervitaminosis D Among Adult 

  Yavuz, DG; Ersoy, R; Altuntas, Y; Bilen, H; Pamuk, B; Apaydin, T; Temizkan, S; Altuntas, H; Mert, M; Akalin, A; Sert, M; Simsri, IY; Hekimsoy, Z; Canturk, Z; Uc, ZA; Iplikci, S; Yasar, M; Unubol, M; Sezer, K; Toplaoglu, O; Iyidir, OT; Pekkolay, Z; Atmaca, A; Dikbas, O; Ozdemir, N; Gul, K; Deniz, F; Ertorer, E; Karaca, Z; Elbuken, G; Arpaci, D; Agbaht, K; Turan, E; Anaforoglu, I; Bayraktaroglu, T; Haklar, G; Daglioglu, G; Tuzcu, A; Sahin, I; Cetinkalp, S (2022)

  Objective: Vitamin D deficiency is a common health problem around the world. This study aimed to evaluate the nationwide prevalence of vitamin D status in tertiary care hospitals in Turkey.
• Real-world data on efficacy and safety of first-line alectinib treatment 

  Hizal, M; Bilgin, B; Paksoy, N; Kilickap, S; Atci, MM; Kahraman, S; Keskinkilic, M; Bilgetekin, I; Ayhan, M; Tural, D; Eren, O; Mustafayev, FNA; Yaman, S; Tatli, AM; Bayram, E; Kutlu, Y; Erturk, I; Ozcan, E; Gulmez, A; Korkmaz, M; Akagunduz, B; Erdem, D; Telli, TA; Aksoy, A; Uskent, N; Iriagac, Y; Baytemur, NK; Aydin, D; Sakalar, T; Arak, H; Selcukbiricik, F; Ergun, Y; Korkmaz, T; Ak, N; Unal, C; Akdeniz, N; Ozgun, MA; Oksuzoglu, B; Yalcin, B; Oztop, I; Algin, E; Sakin, A; Aydiner, A; Yumuk, PF; Sendur, MAN (2022)

  Plain language summary The advancements in cancer treatment, particularly in the last two decades, have been promising. Non-small-cell lung cancer (NSCLC) is one of the most important diseases experiencing these promising ...
• Trends of primary glomerular disease in Turkey: TSN-GOLD registry report 

  Gul, CB; Kucuk, M; Ozturk, S; Demir, E; Eren, N; Sumnu, A; Seyahi, N; Gullulu, M; Dede, F; Derici, U; Koc, Y; Sahin, G; Oymak, O; Sahin, GM; Tatar, E; Dursun, B; Dheir, H; Apaydin, S; Suleymanlar, G; Ulu, S; Altinoren, O; Kutlay, S; Mese, M; Sahin, I; Ustundag, S; Turkmen, K; Yilmaz, ME; Kazancioglu, RT; Uzun, O; Candan, F; Aydin, Z; Oygar, D; Aktas, N; Erdem, Y; Paydas, S; Taymez, D; Can, B; Kiykim, A; Koc, L; Sezer, S; Duranay, M; Bardak, S; Altintepe, L; Kaya, B; Azak, A; Ecder, SA; Cavdar, C; Selcuk, NY (2022)

  Background Although several renal biopsy registry reports have been published worldwide, there are no data on primary glomerular disease trends in Turkey. Methods Three thousand eight-hundred fifty-eight native kidney ...
• Prognostic factors of perioperative FLOT regimen in operable gastric and 

  Erol, C; Sakin, A; Basoglu, T; Ozden, E; Cabuk, D; Dogan, M; Oksuzoglu, B; Yildirim, HC; Oner, I; Eryilmaz, MK; Dulgar, O; Aydin, D; Dogan, N; Ozen, M; Hacibekiroglu, I; Ozdemir, N; Gurler, F; Paksoy, N; Karabulut, S; Aksoy, A; Hizal, M; Kahraman, S; Sen, E; Paydas, S; Cilbir, E; Firat, F; Akdeniz, N; Ozcelik, M; Oyman, A; Baytemur, NK; Acar, R; Almuradova, E; Karabulut, B; Sakalar, T; Arak, H; Degerli, E; Turker, S; Alan, O; Er, O; Tasci, ES; Demir, N; Cavdar, E; Turhal, S; Dede, DS; Akinci, MB; Yalcin, B; Yumuk, F; Yalcin, S; Sendur, MAN (2022)

  Background/aim: Perioperative FLOT regimen is a standard of care in locally advanced operable gastric and GEJ adenocarcinoma. We aimed to determine the efficacy, prognostic factors of perioperative FLOT chemotherapy in ...
• Real life experience of patients with locally advanced gastric and 

  Basoglu, T; Sakin, A; Erol, C; Ozden, E; Cabuk, D; Cilbir, E; Ozyukseler, DT; Ayhan, M; Sendur, MA; Dogan, M; Oksuzoglu, B; Eryilmaz, MK; Er, O; Tasci, ES; Ozyurt, N; Dulgar, O; Ozen, M; Hacibekiroglu, I; Oner, I; Bekmez, ET; Yildirim, HC; Yalcin, S; Paydas, S; Yekeduz, E; Aksoy, A; Ozcelik, M; Oyman, A; Almuradova, E; Karabulut, B; Demir, N; Dincer, M; Ozdemir, N; Erdem, D; Ak, N; Inal, A; Salim, DK; Deniz, GI; Sakalar, T; Gulmez, A; Kacan, T; Ozdemir, O; Alan, O; Unal, C; Karakas, Y; Turhal, S; Yumuk, PF

  Neoadjuvant chemotherapy (NACT) in gastroesophageal junction (GEJ) and gastric cancer (GC) was shown to improve survival in recent studies. We aimed to share our real-life experience of patients who received NACT to compare ...
• Urinary HSP70 improves diagnostic accuracy for urinary tract infection 

  Yilmaz, A; Afonso, AC; Akil, I; Aksu, B; Alpay, H; Atmis, B; Aydog, O; Bayram, MT; Bilge, I; Bulut, IK; Buyukkaragoz, B; Comak, E; Demir, BK; Dincel, N; Donmez, O; Durmus, MA; Dursun, H; Dusunsel, R; Duzova, A; Ertan, P; Gedikbasi, A; Goknar, N; Guven, S; Hacihamdioglu, D; Jankauskiene, A; Kalyoncu, M; Kavukcu, S; Kenan, BU; Kucuk, N; Kural, B; Montini, G; Morello, W; Nayir, A; Obrycki, L; Omer, B; Ozdemir, EM; Ozkayin, N; Paripovic, D; Pehlivanoglu, C; Saygili, S; Schaefer, S; Sonmez, F; Tabel, Y; Tas, N; Tasdemir, M; Teixeira, A; Tekcan, D; Tulpar, S; Turkkan, ON; Uysal, B; Uysalol, M; Vaiciuniene, D; Yavuz, S; Yel, S; Yildirim, T; Yildirim, ZY; Yildiz, N; Yuksel, S; Yurtseven, E; Schaefer, F; Topaloglu, R; Bayazit, AK; Litwin, M

  Background The accuracy of conventional urinalysis in diagnosing urinary tract infection (UTI) in children is limited, leading to unnecessary antibiotic exposure in a large fraction of patients. Urinary heat shock protein ...
• CHARACTERISTICS AND SURVIVAL RESULTS OF PERITONEAL DIALYSIS PATIENTS 

  Gursu, M; Ozturk, S; Arici, M; Sahin, I; Bek, SG; Yilmaz, M; Koyuncu, S; Sirali, SK; Ural, Z; Dursun, B; Yuksel, E; Uzun, S; Sipahi, S; Ahbap, E; Artan, AS; Altunoren, O; Tunca, O; Ayar, Y; Gok-Oguz, E; Yilmaz, Z; Kahvecioglu, S; Asicioglu, E; Oruc, A; Altiparmak, MR; Aydin, Z; Huddam, B; Dolarslan, ME; Azak, A; Bakirdogen, S; Yalcin, AU; Karadag, S; Ulu, MS; Gungor, O; Bakir, EA; Odabas, AR; Seyahi, N; Yildiz, A; Ates, K (2022)

  Background: We aimed to study the characteristics of peritoneal dialysis (PD) patients with Coronavirus disease-19 (COVID-19), determine the short-term mortality and other medical complications, and delineate the factors ...
• URINARY HSP70 IMPROVES DIAGNOSTIC ACCURACY FOR URINARY TRACT INFECTION 

  Yilmaz, A; Afonso, AC; Akil, I; Aksu, B; Alpay, H; Atmis, B; Aydog, O; Bayazit, AK; Bayram, MT; Bilge, I; Bulut, IK; Buyukkaragoz, B; Comak, E; Demir, BK; Dincel, N; Donmez, O; Durmus, MA; Dursun, H; Dusunsel, R; Duzova, A; Ertan, P; Gedikbasi, A; Goknar, N; Guven, S; Hacihamdioglu, D; Jankauskiene, A; Kalyoncu, M; Kavukcu, S; Kenan, BU; Kucuk, N; Kural, B; Litwin, M; Montini, G; Morello, W; Nayir, A; Obrycki, L; Omer, B; Ozdemir, EM; Ozkayin, N; Paripovic, D; Pehlivanoglu, C; Saygili, S; Schaefer, S; Sonmez, F; Tabel, Y; Tas, N; Tasdemir, M; Teixeira, A; Tekcan, D; Tulpar, S; Turkkan, ON; Uysal, B; Uysalol, M; Vaiciuniene, D; Yavuz, S; Yel, S; Yildirim, T; Yildirim, ZY; Yildiz, N; Yuksel, S; Yurtseven, E; Schaefer, F; Topaloglu, R (2022)
• The percentage of ALK-positive cells and the efficacy of first-line 

  Hizal, M; Bilgin, B; Paksoy, N; Atci, MM; Kahraman, S; Kilickap, S; Guven, DC; Keskinkilic, M; Ayhan, M; Eren, O; Mustafayev, FNA; Yaman, S; Bayram, E; Erturk, I; Ozcan, E; Korkmaz, M; Akagunduz, B; Erdem, D; Telli, TA; Aksoy, A; Uskent, N; Baytemur, NK; Gulmez, A; Aydin, D; Sakalar, T; Arak, H; Tatli, AM; Ergun, Y; Ak, N; Unal, C; Ozgun, MA; Yalcin, B; Oztop, I; Algin, E; Sakin, A; Aydiner, A; Yumuk, PF; Sendur, MAN

  Introduction Alectinib is an effective second-generation ALK tyrosine kinase inhibitor (TKI) used in the first-line treatment of patients with advanced ALK-positive NSCLC. Recent studies demonstrated that the percentage ...
• Middle-term outcomes in renal transplant recipients with COVID-19: a 

  Oto, OA; Ozturk, S; Arici, M; Velioglu, A; Dursun, B; Guller, N; Sahin, I; Eser, ZE; Paydas, S; Trabulus, S; Koyuncu, S; Uyar, M; Ural, Z; Sadioglu, RE; Dheir, H; Koc, NS; Ozer, H; Durak, BA; Gul, CB; Kasapoglu, U; Oguz, EG; Tanrisev, M; Kuzgun, GS; Mirioglu, S; Dervisoglu, E; Erken, E; Gorgulu, N; Ozkurt, S; Aydin, Z; Kurultak, I; Ogutmen, MB; Bakirdogen, S; Kaya, B; Karadag, S; Ulu, MS; Gungor, O; Bakir, EA; Odabas, AR; Seyahi, N; Yildiz, A; Ates, K (2022)

  Background In this study, we evaluated 3-month clinical outcomes of kidney transplant recipients (KTR) recovering from COVID-19 and compared them with a control group. Method The primary endpoint was death in the third ...
• The effectiveness and safety of neoadjuvant pertuzumab and trastuzumab 

  Ozdemir, O; Zengel, B; Yildiz, Y; Uluc, BO; Cabuk, D; Ozden, E; Salim, DK; Paydas, S; Demir, A; Diker, O; Pilanci, KN; Sonmez, OU; Vatansever, S; Dogan, I; Gulmez, A; Cakar, B; Gursoy, P; Yildirim, ME; Ayhan, M; Karadurmus, N; Aykan, MB; Cevik, GT; Sakalar, T; Hacibekiroglu, I; Gulbagci, BB; Dincer, M; Garbioglu, DB; Kemal, Y; Nayir, E; Taskaynatan, H; Yilmaz, M; Avci, O; Sari, M; Coban, E; Atci, MM; Esen, SA; Telli, TA; Karatas, F; Inal, A; Demir, H; Kalkan, NO; Yilmaz, C; Tasli, F; Alacacioglu, A (2022)

  In our study, we aimed to evaluate the pathological response rates and side effect profile of adding pertuzumab to the treatment of HER2+ locally advanced, inflammatory, or early-stage breast cancer. This study was conducted ...

Daha Fazla